Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
A marker strongly associated with outcome (or disease) is often assumed to be effective for classifying persons according to their current or future outcome. However, for this assumption to be true, the associated odds ratio must be of a magnitude rarely seen in epidemiologic studies. In this paper, an illustration of the relation between odds ratios and receiver operating characteristic curves shows, for example, that a marker with an odds ratio of as high as 3 is in fact a very poor classification tool. If a marker identifies 10% of controls as positive (false positives) and has an odds ratio of 3, then it will correctly identify only 25% of cases as positive (true positives). The authors illustrate that a single measure of association such as an odds ratio does not meaningfully describe a marker's ability to classify subjects. Appropriate statistical methods for assessing and reporting the classification power of a marker are described. In addition, the serious pitfalls of using more traditional methods based on parameters in logistic regression models are illustrated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, for diagnostic, prognostic, or screening markers in epidemiologic studies, the limited magnitude of the OR considered meaningful (i.e., about or >70) is rarely discussed (36).”
From Misrepresentation and distortion of research in biomedical literature (2018) · cites this paper as [36]
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“Examples include the Framingham risk score for cardiovascular events (2) and the Gail model risk score for breast cancer (3).”
BackgroundA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“Examples from other popular journals are Ridker et al. ( 11 ), Zhang et al. (12), Liou et al. (13), and Hogue et al. (14).”
BackgroundGail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
The Statistical Evaluation of Medical Tests for Classification and Prediction
(2005) · Technometrics · doi:10.1198/tech.2005.s278 · Cited by 1,899
Self-citationCarney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L. A., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,142
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
A family of nonparametric statistics for comparing diagnostic markers with paired or unpaired data
WIEAND, S., GAIL, M. H., JAMES, B. R., & JAMES, K. L. (1989) · Biometrika · doi:10.1093/biomet/76.3.585 · Cited by 355
Cited by
Items 601–700 of 1,000
Shimada, K., Kario, K., Kushiro, T., Teramukai, S., Zenimura, N., Ishikawa, Y., Okuda, Y., & Saito, I. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000966 · Cited by 24
A Practical Roadmap for Clinical Translation of Metabolic Biomarkers: A Review
Kim, K. D., Yoo, M., Choi, M. Y., & Yoo, B. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27042030 · Cited by 24
Hettiarachchi, G. K., & Komar, A. A. (2022) · Springer eBooks · doi:10.1007/978-3-031-05616-1_4 · Cited by 24
Farjah, F., Monsell, S. E., Greenlee, R. T., Gould, M. K., Smith‐Bindman, R., Banegas, M. P., Schoen, K., Ramaprasan, A., & Buist, D. S. M. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.030 · Cited by 24
Gibbins, K. J., Abel, D. E., Carletti, A. A., Morrison, T., Sullivan, E. L., & Marshall, N. (2023) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-023-00348-9 · Cited by 24
Ellis, S. G., Shishehbor, M. H., Kapadia, S. R., Lincoff, A. M., Nair, R., Whitlow, P. L., Bajzer, C., Cho, L., Tuzcu, E. M., Raymond, R. E., et al. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2011.01.006 · Cited by 24
Heo, M., Kabat, G. C., Strickler, H. D., Lin, J., Hou, L., Stefanick, M. L., Anderson, G. L., & Rohan, T. E. (2015) · Journal of Women s Health · doi:10.1089/jwh.2014.4977 · Cited by 24
Boros, A. M., Széplaki, G., Perge, P., Jenei, Z. M., Bagyura, Z., Zima, E., Molnár, L., Apor, A., Becker, D. J., Gellér, L., et al. (2015) · EP Europace · doi:10.1093/europace/euv100 · Cited by 24
Schutte, E., Gansevoort, R. T., Benner, J., Lutgers, H. L., & Heerspink, H. J. L. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv119 · Cited by 24
Body Mass Index Adjusted Prostate-specific Antigen and Its Application for Prostate Cancer Screening
Liang, Y., Ankerst, D. P., Sanchez, M. A., Leach, R. J., & Thompson, I. M. (2010) · Urology · doi:10.1016/j.urology.2010.04.060 · Cited by 24
Wong, M. C. S., Ching, J. Y. L., Ng, S., Lam, T. Y. T., Luk, A. K. C., Wong, S. H., Ng, S. C., Ng, S. S. M., Wu, J. C., Chan, F. K. L., et al. (2016) · Scientific Reports · doi:10.1038/srep20080 · Cited by 24
Boghossian, N. S., Geraci, M., Edwards, E. M., & Horbar, J. D. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.05.002 · Cited by 24
Utility of the 5-Minute Apgar Score as a Research Endpoint
Bovbjerg, M. L., Dissanayake, M. V., Cheyney, M. J., Brown, J., & Snowden, J. M. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz132 · Cited by 24
Li, H., Zhang, S., Kang, J.-Q., Yang, L., & Liu, F. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01244-0 · Cited by 24
Sensitivity Analysis and Bias Analysis
Greenland, S. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_60 · Cited by 24
Nomura, K., Inoue, K., & Akimoto, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036309 · Cited by 24
Towards validation of statistically reliable biomarkers
Buyse, M. E. (2007) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(07)70028-9 · Cited by 24
Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice?
Mureddu, G. F., Brandimarte, F., Faggiano, P. M., Rigo, F., & Nixdorff, U. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes297 · Cited by 26
Köenig, W. (2009) · Annals of Medicine · doi:10.1080/07853890902769675 · Cited by 24
Kent, S. C., Wanzek, J., & Yun, J. (2018) · Assessment for Effective Intervention · doi:10.1177/1534508418758371 · Cited by 24
Identifying target populations for screening or not screening using logic regression
Janes, H., PEPE, M. S., Kooperberg, C. L., & Newcomb, P. A. (2004) · Statistics in Medicine · doi:10.1002/sim.2021 · Cited by 24
Self-citationHuang, W. W., Mao, H., Lee, H.-M., & Chi, W. (2022) · Healthcare · doi:10.3390/healthcare10061139 · Cited by 23
Labarrere, C. A., Woods, J. R., Hardin, J. W., Jaeger, B. R., Zembala, M., Deng, M. C.-H. K., & Kassab, G. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113260 · Cited by 23
Trock, B. J. (2014) · Current Opinion in Urology · doi:10.1097/mou.0000000000000050 · Cited by 23
Brutsaert, E. F., Shitole, S. G., Biggs, M. L., Mukamal, K. J., DeBoer, I., Thacker, E. L., Barzilay, J. I., Djoussé, L., Ix, J. H., Smith, N. L., et al. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv106 · Cited by 23
Dahlin, L. B., Perez, R., Nyman, E., Zimmerman, M., & Merlo, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133871 · Cited by 23
Clinical Application of Gene Expression Profiling in Breast Cancer
Sparano, J. A., Fazzari, M. J., & Kenny, P. A. (2010) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2010.03.008 · Cited by 23
Hellemons, M. E., Heerspink, H. J. L., Gansevoort, R. T., de Zeeuw, D., & Bakker, S. J. L. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835eb5e8 · Cited by 23
Literature-related discovery: common factors for Parkinson’s Disease and Crohn’s Disease
Kostoff, R. N. (2014) · Scientometrics · doi:10.1007/s11192-014-1298-3 · Cited by 23
Predicting three-month functional outcomes after an ED visit for acute low back pain
Friedman, B. W., Gensler, S. A., Yoon, A., Nerenberg, R., Holden, L. M., Bijur, P. E., & Gallagher, E. J. (2016) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2016.11.014 · Cited by 23
The Best Predictors of Survival: Do They Vary by Age, Sex, and Race?
Goldman, N., Glei, D. A., & Weinstein, M. (2017) · Population and Development Review · doi:10.1111/padr.12079 · Cited by 23
Validation of dynamic random dot stereotests in pediatric vision screening
Budai, A., Czigler, A., Mikó–Baráth, E., Nemes, V. Á., Horváth, G., Pusztai, Á., Pinero, D. P., & Jandó, G. (2018) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-018-4147-x · Cited by 23
Quantifying prognosis with risk predictions
Pace, N. L., Eberhart, L. H. J., & Kranke, P. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32834d9474 · Cited by 23
Demsash, A. W. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101298 · Cited by 22
Charpentier, S., Lepage, B., Maupas‐Schwalm, F., Cinq-Frais, C., Bichard-Bréaud, M., Botella, J. M., Elbaz, M., & Lauque, D. (2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.12.018 · Cited by 22
Cytokines Association with Clinical and Pathological Changes in Esophageal Squamous Cell Carcinoma
Diakowska, D. (2013) · Disease Markers · doi:10.1155/2013/302862 · Cited by 22
Role of beta‐defensin 2 and interleukin‐4 receptor as stroke outcome biomarkers
García‐Berrocoso, T., Giralt, D., Bustamante, A., Llombart, V., Rubiera, M., Peñalba, A., Boada, C., Espadaler, M., Molina, C. A., & Montaner, J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12649 · Cited by 22
Evidence-based analysis of risk factors for sudden cardiac death
Goldberger, J. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.11.007 · Cited by 21
Eom, B. W., Joo, J., Park, B., Jo, M. J., Choi, S. H., Cho, S., Ryu, K. W., Kim, Y., & Kook, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159424 · Cited by 22
Lebenbaum, M., Espin‐Garcia, O., Li, Y., & Rosella, L. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191169 · Cited by 22
Regularized binormal ROC method in disease classification using microarray data
Ma, S., Song, X., & Huang, J. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-253 · Cited by 22
Zhou, X., Chen, B., Xie, Y., Tian, F., Liu, H., & Liang, X. (2011) · Statistics in Medicine · doi:10.1002/sim.3980 · Cited by 22
Doust, J. A., Baneshi, M. R., Chung, H., Wilson, L. F., & Mishra, G. D. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.123.010842 · Cited by 21
Biomarkers and transcriptome profiling of lung cancer
Chen, H., Yu, S., Li, K.-C., & Yang, P. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02154.x · Cited by 21
Verouden, N. J. W., Haeck, J. D. E., Kuijt, W. J., van Geloven, N., Koch, K. T., Henriques, J. P. S., Baan, J., Vis, M. M., Piek, J. J., Tijssen, J. G. P., et al. (2010) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.923797 · Cited by 19
Henegar, C., Westreich, D. J., Maskew, M., Brookhart, M. A., Miller, W. C., Majuba, P., & Rie, A. V. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0953-2 · Cited by 21
Dhawan, A., Graham, T. A., & Fletcher, A. G. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0248 · Cited by 21
Predicting the risk of recurrent venous thrombosis: What the future might bring
Lijfering, W. M., Timp, J. F., & Cannegieter, S. C. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14534 · Cited by 21
Moya-Angeler, J., Vairo, G. L., Bader, D. A., Sebastianelli, W. J., & Sherbondy, P. S. (2021) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2021.08.018 · Cited by 21
Risk Scores for Prediction of Coronary Heart Disease: An Update
Wilson, P. W. F. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.001 · Cited by 21
Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease
Brevetti, G., Laurenzano, E., Giugliano, G., Lanero, S., Brevetti, L., Luciano, R., & Chiariello, M. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.05.016 · Cited by 21
Juárez, S., Wagner, P., & Merlo, J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005388 · Cited by 21
Revisiting the discriminatory accuracy of traditional risk factors in preeclampsia screening
Rodríguez‐López, M., Wagner, P., Vicente, R. P., Crispi, F., & Merlo, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178528 · Cited by 21
Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer
Thornblade, L. W., Mulligan, M. S., Odem‐Davis, K., Hwang, B., Waworuntu, R. L., Wolff, E. M., Kessler, L. G., Wood, D. E., & Farjah, F. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.06.022 · Cited by 21
Shi, W., Liu, S., Li, J., Tian, Y., & Xing, L. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1595983 · Cited by 21
A boosting method for maximization of the area under the ROC curve
Komori, O. (2009) · Annals of the Institute of Statistical Mathematics · doi:10.1007/s10463-009-0264-y · Cited by 21
The trend odds model for ordinal data
Capuano, A. W., & Dawson, J. D. (2012) · Statistics in Medicine · doi:10.1002/sim.5689 · Cited by 21
Lusa, L., McShane, L. M., Radmacher, M. D., Shih, J. H., Wright, G. W., & Simon, R. M. (2006) · Statistics in Medicine · doi:10.1002/sim.2598 · Cited by 21
Maternal Serum Granulocyte Colony-Stimulating Factor Levels and Spontaneous Preterm Birth
Whitcomb, B. W., Schisterman, E. F., Luo, X., & Chegini, N. (2008) · Journal of Women s Health · doi:10.1089/jwh.2008.0883 · Cited by 21
Metabolic syndrome and risk for Type 2 diabetes
Meigs, J. B. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.57 · Cited by 22
Five-minute Apgar score and outcomes in neonates of 24–28 weeks’ gestation
Shah, P. S., Norman, M., Rusconi, F., Kusuda, S., Reichman, B. L., BATTIN, M. R., Bassler, D., Modi, N., Håkansson, S., Yang, J., et al. (2021) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2021-322230 · Cited by 20
Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes
Baker, S. G., & Kramer, B. S. (2014) · Clinical Trials · doi:10.1177/1740774514557725 · Cited by 19
Ye, Q., Putila, J. J., Raese, R. A., Dong, C., Qian, Y. R., Dowlati, A., & Guo, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147658 · Cited by 20
American College of Endocrinology Pre-Diabetes Consensus Conference: Part One
Bloomgarden, Z. T. (2008) · Diabetes Care · doi:10.2337/dc08-zb10 · Cited by 20
Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
Cai, T., & Zheng, Y. (2011) · Journal of the American Statistical Association · doi:10.1198/jasa.2011.tm09807 · Cited by 20
Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients
Freiesleben, N. L. C., Gerds, T. A., Forman, J. L., Silver, J. D., Andersen, A. N., & Popovic-Todorovic, B. (2010) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2010.08.010 · Cited by 20
Vascular comorbidities and demographics of patients with ruptured abdominal aortic aneurysms
Vänni, V., Turtiainen, J., Hakala, T., Salenius, J., Suominen, V., Oksala, N., & Hernesniemi, J. A. (2015) · Surgery · doi:10.1016/j.surg.2015.10.005 · Cited by 20
Risk assessment to guide cervical screening strategies in a large C hinese population
Zhao, F., Hu, S., Zhang, Q., Zhang, X., Pan, Q., Zhang, W., Gage, J. C., Wentzensen, N., Castle, P. E., Qiao, Y., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30012 · Cited by 20
Lee, S. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280207084839 · Cited by 20
A modified area under the ROC curve and its application to marker selection and classification
Yu, W., Chang, Y. I., & Park, E. (2013) · Journal of the Korean Statistical Society · doi:10.1016/j.jkss.2013.05.003 · Cited by 20
Improving risk classification of critical illness with biomarkers: A simulation study
Seymour, C. W., Cooke, C. R., Wang, Z., Kerr, K. F., Yealy, D. M., Angus, D. C., Rea, T. D., Kahn, J. M., & PEPE, M. S. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.12.001 · Cited by 20
Self-citationTripepi, G. L., Pannier, B., D’Arrigo, G., Mallamaci, F., Zoccali, C., & London, G. M. (2016) · Kidney International · doi:10.1016/j.kint.2016.10.012 · Cited by 20
The Role of Macrosocial Determinants in Shaping the Health of Populations
Galea, S., & Putnam, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70812-6_1 · Cited by 20
Blood Pressure Management in the 21st Century: Maximizing Gains and Minimizing Waste
Rahimi, K., & MacMahon, S. W. (2013) · Circulation · doi:10.1161/circulationaha.113.006218 · Cited by 20
Hwang, A. B., Schuepfer, G., Pietrini, M., & Boes, S. (2021) · PLOS ONE · doi:10.1371/journal.pone.0258338 · Cited by 19
“As an overall performance measure, composed of discrimination and calibration, the Brier score was calculated [36].”
MethodFranco‐Pereira, A. M., Nakas, C. T., & Pardo, M. D. C. (2020) · AStA Advances in Statistical Analysis · doi:10.1007/s10182-020-00371-8 · Cited by 19
Lipoprotein(a): a causal independent risk factor for coronary heart disease?
Gudnason, V. G. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832f0a5b · Cited by 19
Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients
Palatini, P., Saladini, F., Mos, L., Benetti, E., Bortolazzi, A., Cozzio, S., & Casiglia, E. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.32 · Cited by 19
First things first: risk model performance metrics should reflect the clinical application
Kerr, K. F., & Janes, H. (2017) · Statistics in Medicine · doi:10.1002/sim.7341 · Cited by 19
Biomarkers in Spondyloarthropathies
Chen, C., Yu, D. T. Y., & Chou, C. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0298-6_9 · Cited by 19
Landmark risk prediction of residual life for breast cancer survival
Parast, L. M., & Cai, T. (2013) · Statistics in Medicine · doi:10.1002/sim.5776 · Cited by 19
Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities
Prasad, R. B., Hakaste, L., & Tuomi, T. (2025) · Diabetologia · doi:10.1007/s00125-025-06419-1 · Cited by 20
Lord, S. J., Horvath, A. R., Sandberg, S., Monaghan, P. J., Cobbaert, C. M., Reim, M., Tolios, A., Mueller, R., & Bossuyt, P. M. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2453148 · Cited by 18
Personalized medicine and the genotype–phenotype dilemma
Roden, D. M. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9561-5 · Cited by 18
Dardas, T., Li, Y., Reed, S. D., O’Connor, C. M., Whellan, D. J., Ellis, S. J., Schulman, K. A., Kraus, W. E., Forman, D. E., & Levy, W. C. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.03.017 · Cited by 18
Shiffman, D., O’Meara, E. S., Rowland, C. M., Louie, J. Z., Cushman, M., Tracy, R. P., Devlin, J. J., & Psaty, B. M. (2011) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-11-10 · Cited by 18
Lagerlund, M., Merlo, J., Vicente, R. P., & Zackrisson, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140244 · Cited by 20
Simpson's paradox in the integrated discrimination improvement
Chipman, J., & Braun, D. (2016) · Statistics in Medicine · doi:10.1002/sim.6862 · Cited by 18
Colaco, K., Lee, K., Akhtari, S., Winer, R., Chandran, V., Harvey, P., Cook, R. J., Piguet, V., Gladman, D. D., & Eder, L. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42694 · Cited by 18
What’s in a Word? The Person of Personalized (nano)Medicine
Guchet, X. (2015) · Nanomedicine · doi:10.2217/nnm.15.145 · Cited by 18
Perry, I. J. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s11-004 · Cited by 18
Adiponectin, Leptin, and Insulin-Pathway Receptors as Endometrial Cancer Subtyping Markers
Busch, E. L., Crous‐Bou, M., Prescott, J., Downing, M. J., ROSNER, B. A., Mutter, G. L., & Vivo, I. D. (2018) · Hormones and Cancer · doi:10.1007/s12672-017-0318-1 · Cited by 18
Sebastian, A. S., Goyal, A., Alvi, M. A., Wahood, W., Elminawy, M., Habermann, E. B., & Bydon, M. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.02.049 · Cited by 18
A gene sets approach for identifying prognostic gene signatures for outcome prediction
Kim, S., & Kim, S. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-177 · Cited by 18
Arnold, N., & Köenig, W. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256242 · Cited by 18
Hung, J., Knuiman, M. W., Divitini, M., Langton, P. E., Chapman, C., & Beilby, J. P. (2007) · Heart Lung and Circulation · doi:10.1016/j.hlc.2007.07.002 · Cited by 18
Incorporating monotonicity into the evaluation of a biomarker
Ghosh, D. (2006) · Biostatistics · doi:10.1093/biostatistics/kxl018 · Cited by 18
Risk prediction and finding new independent prognostic factors
D’Agostino, R. B. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000217845.57466.cc · Cited by 18
From Averages to Heterogeneity: A Plain-Language Guide to MAIHDA in Epidemiology
Merlo, J., Kaufman, J. S., & Leckie, G. (2026) · International Journal of Social Determinants of Health and Health Services · doi:10.1177/27551938261423042 · Cited by 17
Bhattacharyya, S., Schoeler, T., Patel, R., Forti, M. D., Murray, R. M., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.016 · Cited by 17
Metadata
- Authors
- Pepe, M. S.
- Affiliations
- Fred Hutch Cancer Center (US)
- Corresponding author
- Pepe, M. S.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 159
- Issue
- 9
- Pages
- 882-890
- ISSN
- 0002-9262 (ISSN-L)
- OpenAlex
- W2121514893
- Cited by
- 1,276
- References
- 27
- Citations by year
- 2026: 56 · 2025: 44 · 2024: 21 · 2023: 35 · 2022: 39 · 2021: 46 · 2020: 46 · 2019: 46 · 2018: 68 · 2017: 63 · 2016: 69 · 2015: 69 · 2014: 72 · 2013: 73 · 2012: 82
- FWCI
- 41.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (U01CA86368, U01CA074794, P01 CA18029, U01CA086368, P01CA018029)
- National Institute of General Medical Sciences (R01 GM 54438, R01GM054438)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- odds ratio, diagnostic biomarkers, prognostic factors, screening marker, receiver operating characteristic, classification accuracy, false positives, true positives, logistic regression, association measures
- MeSH terms
- Classification, Data Interpretation, Statistical, Epidemiologic Methods, False Positive Reactions, Humans, Mass Screening, Predictive Value of Tests, Prognosis, Risk Factors, ROC Curve, Reproducibility of Results, Biomarkers, Discriminant Analysis, Logistic Models, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.